The excerpt does not say how the tools will be deployed, who will use them, or what difference early detection makes in this context. The available detail is too thin to name a specific mechanism.
Most affected
Patients with early-stage kidney disease — May be identified sooner than current diagnostic methods allow.
Likely next
Whether the tools receive regulatory approval or are deployed in clinical settings.
